Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database

Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database

Rimple Jeet Kaur,1 Jaykaran Charan,2 Siddhartha Dutta,2 Paras Sharma,3 Pankaj Bhardwaj,4 Praveen Sharma,5 Halyna Lugova,6 Ambigga Krishnapillai,7 Salequl Islam,8 Mainul Haque,9 Sanjeev Misra10 1Department of Pharmacology, Dr. S.N Medical College, Jodhpur, Rajasthan, India; 2Department of Pharmacolog...

Full description

Bibliographic Details
Main Authors: Kaur RJ, Charan J, Dutta S, Sharma P, Bhardwaj P, Lugova H, Krishnapillai A, Islam S, Haque M, Misra S
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Infection and Drug Resistance
Subjects:
favipiravir
usage
sars-cov-2
scrutiny
assumed
adverse drug events
described
world health organization
record
Online Access:https://www.dovepress.com/favipiravir-use-in-covid-19-analysis-of-suspected-adverse-drug-events--peer-reviewed-article-IDR

Internet

https://www.dovepress.com/favipiravir-use-in-covid-19-analysis-of-suspected-adverse-drug-events--peer-reviewed-article-IDR

Similar Items